• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定义深度缓解期炎症性肠病患儿的正常肠壁厚度:一项代表国际肠道超声组(IBUS)儿科委员会开展的多中心研究。

Defining normal bowel wall thickness in children with inflammatory bowel disease in deep remission: A multicenter study on behalf of the pediatric committee of the International Bowel Ultrasound Group (IBUS).

作者信息

Kellar Amelia, Chavannes Mallory, Huynh Hien Q, Aronskyy Illya, Lei Bryan, deBruyn Jennifer C, Kim Justin, Dolinger Michael T

机构信息

Section of Pediatric Gastroenterology, Hepatology and Nutrition, Comer Children's Hospital at the University of Chicago, Chicago, Illinois, USA.

Division of Gastroenterology, Hepatology, and Nutrition, Children's Hospital Los Angeles, Department of Pediatrics, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA.

出版信息

J Pediatr Gastroenterol Nutr. 2025 Jul;81(1):53-61. doi: 10.1002/jpn3.70049. Epub 2025 Apr 29.

DOI:10.1002/jpn3.70049
PMID:40296563
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12210792/
Abstract

OBJECTIVES

Intestinal ultrasound (IUS) is a noninvasive tool for detecting and monitoring disease activity in children with inflammatory bowel disease (IBD). Remission values for bowel wall thickness (BWT) are extrapolated from adult data. We aimed to define normal BWT in children with IBD in sustained deep remission.

METHODS

Multicenter, retrospective pediatric IUS database including children with IBD, without a history of surgery or complications, who underwent IUS after achieving sustained deep remission, defined as the absence of ulcerations on ileocolonoscopy and/or transmural healing on magnetic resonance enterography and steroid-free clinical remission for ≥6 months. Univariate and multivariable analyses were performed using mixed-effect modeling.

RESULTS

Ninety-eight children (40 [41%] female; 64 [5%] Crohn's disease [CD]: 29 (30%) ulcerative colitis [UC]: 5 (5%) IBD-unspecified), median age 15.2 [13.8-16.8] years), and 484 bowel segments were included. Median BWT was 1.4 (1.1-1.6) mm, with no difference in BWT between bowel segments (p = 0.28). In multivariable analysis, a positive association remained between BWT and weight (univariate β = 0.004 [95% confidence interval, CI = 0.001-0.007], p = 0.016, multivariate β = 0.006 [95% CI = 0.001-0.011], p = 0.041). A negative association remained between BWT and disease duration (unadjusted β = -0.024 [95% CI = -0.047 to -0.001] p = 0.046, adjusted β = -0.028 [95% CI = -0.052 to -0.003], p = 0.039).

CONCLUSION

Previously inflamed BWT for children with IBD in sustained deep remission was less than 2.5 mm, which is less than 3 mm in adults, and unaffected by age, sex, and bowel segment in this population. BWT may be affected by weight and disease duration. These findings are crucial to the standardized assessment of transmural healing in children.

摘要

目的

肠道超声(IUS)是一种用于检测和监测炎症性肠病(IBD)患儿疾病活动的非侵入性工具。肠壁厚度(BWT)的缓解值是根据成人数据推断出来的。我们旨在确定处于持续深度缓解期的IBD患儿的正常BWT。

方法

多中心回顾性儿科IUS数据库,纳入了无手术或并发症史、在实现持续深度缓解后接受IUS检查的IBD患儿。持续深度缓解定义为回结肠镜检查无溃疡和/或磁共振肠造影显示透壁愈合,且无类固醇临床缓解≥6个月。使用混合效应模型进行单变量和多变量分析。

结果

纳入了98名儿童(40名[41%]女性;64名[5%]克罗恩病[CD]:29名[30%]溃疡性结肠炎[UC]:5名[5%]未特定的IBD),中位年龄15.2[13.8 - 16.8]岁,以及484个肠段。中位BWT为1.4(1.1 - 1.6)mm,肠段之间的BWT无差异(p = 0.28)。在多变量分析中,BWT与体重之间仍存在正相关(单变量β = 0.004[95%置信区间,CI = 0.001 - 0.007],p = 0.016,多变量β = 0.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e1a/12210792/025b6aeed1a2/JPN3-81-53-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e1a/12210792/7dc1c2e19449/JPN3-81-53-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e1a/12210792/025b6aeed1a2/JPN3-81-53-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e1a/12210792/7dc1c2e19449/JPN3-81-53-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e1a/12210792/025b6aeed1a2/JPN3-81-53-g001.jpg

相似文献

1
Defining normal bowel wall thickness in children with inflammatory bowel disease in deep remission: A multicenter study on behalf of the pediatric committee of the International Bowel Ultrasound Group (IBUS).定义深度缓解期炎症性肠病患儿的正常肠壁厚度:一项代表国际肠道超声组(IBUS)儿科委员会开展的多中心研究。
J Pediatr Gastroenterol Nutr. 2025 Jul;81(1):53-61. doi: 10.1002/jpn3.70049. Epub 2025 Apr 29.
2
Maintenance treatment with vedolizumab in paediatric inflammatory bowel disease (VEDOKIDS): 54-week outcomes of a multicentre, prospective, cohort study.维多珠单抗用于儿童炎症性肠病的维持治疗(VEDOKIDS):一项多中心、前瞻性队列研究的54周结果
Lancet Gastroenterol Hepatol. 2025 Mar;10(3):234-247. doi: 10.1016/S2468-1253(24)00319-4. Epub 2025 Jan 6.
3
Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.干预措施用于克罗恩病和炎症性肠病的腹痛管理。
Cochrane Database Syst Rev. 2021 Nov 29;11(11):CD013531. doi: 10.1002/14651858.CD013531.pub2.
4
Vitamin D for the treatment of inflammatory bowel disease.维生素 D 治疗炎症性肠病。
Cochrane Database Syst Rev. 2023 Oct 2;10(10):CD011806. doi: 10.1002/14651858.CD011806.pub2.
5
Enteral nutritional therapy for induction of remission in Crohn's disease.肠内营养疗法诱导克罗恩病缓解
Cochrane Database Syst Rev. 2018 Apr 1;4(4):CD000542. doi: 10.1002/14651858.CD000542.pub3.
6
Patient education interventions for the management of inflammatory bowel disease.炎症性肠病管理的患者教育干预措施。
Cochrane Database Syst Rev. 2023 May 4;5(5):CD013854. doi: 10.1002/14651858.CD013854.pub2.
7
Stem cell transplantation for induction of remission in medically refractory Crohn's disease.干细胞移植治疗药物难治性克罗恩病诱导缓解。
Cochrane Database Syst Rev. 2022 May 13;5(5):CD013070. doi: 10.1002/14651858.CD013070.pub2.
8
Withdrawal of immunosuppressant or biologic therapy for patients with quiescent Crohn's disease.对病情缓解的克罗恩病患者停用免疫抑制剂或生物疗法。
Cochrane Database Syst Rev. 2018 May 12;5(5):CD012540. doi: 10.1002/14651858.CD012540.pub2.
9
Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.检测炎症性肠病患者结肠癌和/或发育异常的策略。
Cochrane Database Syst Rev. 2006 Apr 19(2):CD000279. doi: 10.1002/14651858.CD000279.pub3.
10
Aminosalicylates for induction of remission or response in Crohn's disease.用于诱导克罗恩病缓解或反应的氨基水杨酸盐。
Cochrane Database Syst Rev. 2016 Jul 3;7(7):CD008870. doi: 10.1002/14651858.CD008870.pub2.

引用本文的文献

1
Is Transmural Healing an Achievable Goal in Inflammatory Bowel Disease?透壁愈合是炎症性肠病可实现的目标吗?
Pharmaceuticals (Basel). 2025 Jul 27;18(8):1126. doi: 10.3390/ph18081126.
2
Sonographic features of axial torsion of Meckel's diverticulum in 12 pediatric patients: a retrospective analysis and literature review.12例儿科患者梅克尔憩室轴扭转的超声特征:一项回顾性分析及文献综述
BMC Pediatr. 2025 Jul 23;25(1):564. doi: 10.1186/s12887-025-05826-y.

本文引用的文献

1
Crohn's disease.克罗恩病。
Lancet. 2024 Mar 23;403(10432):1177-1191. doi: 10.1016/S0140-6736(23)02586-2. Epub 2024 Mar 1.
2
Early Intestinal Ultrasound Response to Biologic Therapy Predicts Endoscopic Remission in Children with Ileal Crohn's Disease: Results from the Prospective Super Sonic Study.早期肠超声对生物治疗的反应可预测回肠克罗恩病儿童的内镜缓解:来自前瞻性 Super Sonic 研究的结果。
J Crohns Colitis. 2024 Aug 6;18(7):1002-1011. doi: 10.1093/ecco-jcc/jjad216.
3
Leaving behind the Mucosa: Advances and Future Directions of Intestinal Ultrasound in Ulcerative Colitis.
超越黏膜:溃疡性结肠炎肠道超声的进展与未来方向
J Clin Med. 2023 Dec 8;12(24):7569. doi: 10.3390/jcm12247569.
4
Determining the Accuracy of Intestinal Ultrasound Scores as a Prescreening Tool in Crohn's Disease Clinical Trials.评估肠超声评分作为克罗恩病临床试验初筛工具的准确性。
Am J Gastroenterol. 2024 May 1;119(5):930-936. doi: 10.14309/ajg.0000000000002632. Epub 2023 Dec 22.
5
Bedside Intestinal Ultrasound Predicts Disease Severity and the Disease Distribution of Pediatric Patients With Inflammatory Bowel Disease: A Pilot Cross-sectional Study.床旁肠道超声预测儿科炎症性肠病患者的疾病严重程度和疾病分布:一项初步的横断面研究。
Inflamm Bowel Dis. 2024 Mar 1;30(3):402-409. doi: 10.1093/ibd/izad083.
6
Assessing Disease Activity in Pediatric Crohn's Disease Using Ultrasound: The Pediatric Crohn Disease Intestinal Ultrasound Score.利用超声评估小儿克罗恩病的疾病活动度:小儿克罗恩病肠道超声评分。
J Pediatr Gastroenterol Nutr. 2023 May 1;76(5):582-589. doi: 10.1097/MPG.0000000000003727. Epub 2023 Feb 7.
7
Intestinal Ultrasound for the Pediatric Gastroenterologist: A Guide for Inflammatory Bowel Disease Monitoring in Children: Expert Consensus on Behalf of the International Bowel Ultrasound Group (IBUS) Pediatric Committee.小儿胃肠病学家的肠道超声:儿童炎症性肠病监测指南:国际肠超声组织(IBUS)小儿委员会专家共识。
J Pediatr Gastroenterol Nutr. 2023 Feb 1;76(2):142-148. doi: 10.1097/MPG.0000000000003649. Epub 2022 Oct 28.
8
Intestinal Ultrasound to Assess Ulcerative Colitis Disease Activity in Children: External Validation and Comparison of 2 Intestinal Ultrasound Activity Indices.肠超声评估儿童溃疡性结肠炎疾病活动度:两种肠超声活动指数的外部验证和比较。
Inflamm Bowel Dis. 2023 Aug 1;29(8):1217-1222. doi: 10.1093/ibd/izac197.
9
Spectrum of bowel wall thickening on ultrasound with pathological correlation in children.小儿肠壁增厚的超声表现与病理相关性分析。
Pediatr Radiol. 2022 Aug;52(9):1786-1798. doi: 10.1007/s00247-022-05376-w. Epub 2022 May 6.
10
Defining Transabdominal Intestinal Ultrasound Treatment Response and Remission in Inflammatory Bowel Disease: Systematic Review and Expert Consensus Statement.定义炎症性肠病经腹肠超声治疗反应和缓解的标准:系统评价和专家共识声明。
J Crohns Colitis. 2022 May 10;16(4):554-580. doi: 10.1093/ecco-jcc/jjab173.